Time in Range, or TIR, is quickly becoming a metric everyone is talking about in diabetes. Whether you’re a TIR expert, or you just learned about this new metric, learn how Michael Hattori used this helpful measurement to help him achieve type 2 diabetes remission. Continue Reading »

How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated with a lower risk of nerve damage in people with diabetes. Continue Reading »

Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications. Continue Reading »

Glucagon is a hormone released by your pancreas that raises the amount of glucose in your blood to help make sure you don’t develop hypoglycemia. Unfortunately, people with type 1 diabetes may have an impaired glucagon response. Researchers are investigating a new medication to stimulate glucagon release, to prevent hypoglycemia for people with type 1 diabetes. Continue Reading »

At the EASD 2021 conference, leading healthcare professionals discussed the importance of prediabetes, what the science says about its complications, and how we should approach treatment. Continue Reading »

Dexcom and Garmin now offer a way to see your glucose levels and trends on your compatible Garmin smartwatch or cycling computer. Don Muchow, a seasoned extreme endurance athlete with type 1 diabetes, shares his experience with this new feature. Continue Reading »

Halloween can be a tricky holiday to navigate. Here are some ways to make trick or treating safe for people with diabetes and some other fun activities to do that don't center around candy. Continue Reading »

A clinical trial by Lilly is seeing if your Time in Range could improve from taking Lyumjev, a ultra-rapid mealtime insulin, along with long acting insulin glargine. Continue Reading »